Image

Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia

Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia

Recruiting
18-85 years
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia.

Description

This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia. Successful ablation is defined as no evidence of local recurrence at 12 months after HybridAPC upon follow up endoscopy. This is defined as absence of LGIN, HGIN and cancer in biopsies obtained at all locations during followup endoscopy.

Eligibility

Inclusion Criteria:

  1. Low grade intraepithelial neoplasia of stomach with sizeā‰¤20 mm
  2. Endoscopic diagnosis suspected gastric LGIN with biopsy confirmed gastric LGIN
  3. Endoscopic appearance according to Paris classification of Type 0-IIa, IIb or IIc
  4. Patients with informed consent

Exclusion Criteria:

  1. Patients who had previous endoscopic treatment (including APC, EMR, ESD) for gastric LGIN, HGIN or gastric carcinoma.
  2. Endoscopic evidence of ulcer
  3. Biopsy confirmed HGIN
  4. Endoscopic diagnosis suspected HGIN while biopsy confirmed LGIN
  5. Pregnancy
  6. informed consent not available

Study details
    Gastric Low Grade Intraepithelial Neoplasia

NCT04197180

Chinese University of Hong Kong

26 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.